Popular Pig® Podcast

Navigating Ag-Tech Innovation and Investment | Joel Harris

Share this:

About the Guest

Leadership & Advocacy

Joel Harris is an active member in Iowa’s biotechnology industry through both of his roles; CEO of Genvax Technologies and Executive Director of the Ag Startup Engine. As co-founder and CEO of Genvax Technologies, Joel is leading his team to develop mRNA + nanoparticle vaccines for livestock. The Genvax team is targeting multiple diseases, most notably swine influenza and the foreign animal disease African Swine Fever. This work requires unique and extensive collaborations that Joel has initiated with state and national leaders in the human and animal biotechnology space, government groups such as the USDA Center for Veterinary Biologics and IEDA and supporting stakeholders like United Animal Health, Iowa Corn Growers Association and Johnsonville Ventures. During 2023 Joel will be networking with government leaders to advocate for support for emerging technologies and bringing those technologies to Iowa.

As Executive Director of the Ag Startup Engine, Joel is instrumental in supporting Iowa-based biotechnology companies. Biotechnology companies that Joel has led investments in are Leah Laboratories, Mazen Animal Health, GW Nutrition, Gross-Wen Technologies, Skroot Laboratories and Pyrone Systems. Joel has served on the boards of IowaBio and Mazen Animal Health. He and his father founded Harrisvaccines (a livestock vaccine company later acquired by Merck Animal Health) that still operates in the ISU Research Park today. During his tenure, Ag Startup Engine was presented with the LWBJ Impact Award for the 2021 Prometheus Awards. Joel is deeply involved in the biotechnology industry in Iowa and continues to bring talent, jobs, and new technologies to the state.

Innovation

At Harrisvaccines, Joel applied unique sales and marketing strategies to bring the first mRNA vaccines to market in the animal health industry. At that time, mRNA was referred to as repliconRNA and was delivered via a viral particle (nanoparticles are the delivery vehicle for Covid mRNA vaccines). Harrisvaccines was initially denied a pathway to regulatory approval by USDA and Joel (as the case with many startups hampered by regulations) created badly needed cash flow for the company by providing swine producers with farm specific vaccines without the requirement for regulatory approval. Eventually, Harrisvaccines assisted the USDA in developing the regulatory requirements for prescription-based farm specific vaccines that is currently followed by Merck Animal Health. At Genvax, Joel is again applying innovation to the development of mRNA/nanoparticle vaccines for animals.

Joel Harris

What can you expect to learn from this episode of Popular Pig?

  • How Harrisvaccines became a successful ag-tech startup and led to a major acquisition by Merck.
  • Why building a supportive community is essential for entrepreneurs in agriculture.
  • The unique challenges that slow down technology adoption in farming compared to other industries.
  • How venture capital models need to be adapted to fit the slower innovation cycles in agriculture.
  • Why deep domain expertise and understanding of producers’ needs are critical for ag-tech success.

Transcript Disclaimer: This transcript was generated using AI-powered transcription software and may contain errors, including incorrect names, industry terminology, or words that were not accurately captured. For the most accurate representation of the conversation, please refer to the original audio or video recording.

Automatically Transcribed With AI

Matthew Rooda 00:00:17 Welcome to the popular pig podcast. I’m your host, Matthew Roda, and today we’re joined by Joel and Michaela. Excited to have you guys here.

Joel Harris 00:00:23 Thanks for having us. Good to be here.

Matthew Rooda 00:00:25 So today we’re going to be talking about ag tech venture capital, a little bit about what the past decade has looked like, some of the systems that have been put in place, how those have fared. and more of a broad and, and a good example with what you guys have been able to do in Ames and then look towards the future of ag tech and, and capital availability and what we think is likely or not. And we’ll call it the animal ag space towards the end there. And so if we could start by having you both share your initial step into entrepreneurship, the ag environment. We’ll start with Joel, because your story predates Michaela and I’s.

Joel Harris 00:01:11 This means you’re saying old. Yeah. Oh, man. And you.

Matthew Rooda 00:01:14 Went.

Joel Harris 00:01:14 You went.

Matthew Rooda 00:01:15 To. You went to a pretty renowned university.

Joel Harris 00:01:17 Right I did. Yeah. To the University of Iowa. That was a good one. That’s a good one. Well, yeah. And that’s funny too, because I grew up in Ames, Iowa, and both my parents are, DVM, PhDs in, epidemiology, immunology. And then, yeah, I got their veterinary medicine degree from Iowa State. So I was kind of a trader when I went to Iowa.

Matthew Rooda 00:01:41 Because your dad had a pretty close tie to the Iowa State, but also a long history in the industry with pick and so on. Right.

Joel Harris 00:01:48 Yeah. So he, he’s actually credited with the simultaneous discovery with his friend doctor Tom Alexander from the University of Cambridge. Out in the UK for discovering the agent that causes swine dysentery. So he this is like in the early 70s. He named it.

Matthew Rooda 00:02:09 what do you name it?

Joel Harris 00:02:11 back. let’s see. It’s a spy receipt. Oh, he’ll kill me on that.

Matthew Rooda 00:02:18 Oh, he’s gonna be mad.

Joel Harris 00:02:19 Yeah. He’s mad.

Matthew Rooda 00:02:20 He has it.

Joel Harris 00:02:21 He has it tattooed on his arm. Oh, wow. Like, electron microscope image of it. That’s pretty cool. So. Yeah. yeah, it’s a spy rocket. It’s a bacteria. I know that.

Matthew Rooda 00:02:33 right.

Joel Harris 00:02:34 But and it’s actually been renamed since then, which is kind of interesting. but yeah, then he helped start Noble Labs, which eventually got bought. So that had a vaccine for swine dysentery that eventually got bought by, by in the 80s, something like that. And then you had a long history at Picc doing their herd health management. purge eradication traveled all over the world, that type of thing. And then.

Matthew Rooda 00:03:00 That part didn’t go as well. I don’t think. Right. He was able.

Joel Harris 00:03:03 To do it in certain places. And also, you know, part of pseudo rabies eradication, different outbreaks like in the Dominican Republic and stuff like that. So there were.

Matthew Rooda 00:03:14 Certain times because pseudo rabies had a case of that, and then pers there trying to figure out how do we want to approach eradicating that from the stakes.

Joel Harris 00:03:23 Which.

Matthew Rooda 00:03:23 It’s it’s a tall task. Yeah. Yeah.

Joel Harris 00:03:27 Yeah. So really I mean really prolific, you know, history. and then went back to the university. We moved back in the mid 90s, to Ames. I was bringing this up. It’s interesting. So do you know the International Pig Veterinary Society meeting? It’s an international meeting.

Matthew Rooda 00:03:48 It moves around.

Joel Harris 00:03:49 Every two years. It moves around. Yeah. It’s only been in the United States once, and it’s Was in Ames, Iowa, and my dad hosted that meeting in 2002. Usually these meetings are in like big cities internationally. but it’s the only time it’s been in the US. It’s been in Ames, Iowa. So there’s like a claim to fame there. That’s cool. so and it was around that time that he started working on these novel, delivery systems for vaccines against Pers, but also against swine influenza and some other things. And I was at the University of Iowa getting a degree in economics, trying to stay as far away from animal health as possible.

Matthew Rooda 00:04:29 And.

Joel Harris 00:04:31 he came on one of his, like, fatherly visits to Iowa City, and we went to a Starbucks, and he was telling me what he was working on and that he had this idea for a vaccine company. He was showing me data that I didn’t really understand at the time. And my fundamental question was like, well, why does anybody care about this? And he said, well, like most of the commercially available vaccines at the time are utilizing 30 or 40 year old technology. And I was really, you know, 21 and a naive kid and thinking, well, that’s ridiculous. Nobody uses 40 year old technology for anything. Like, obviously this is better. We should do it. And so that’s how I got, kind of brought into biotech, animal health, and entrepreneurship.

Matthew Rooda 00:05:22 And so yeah, that was Harris vaccine.

Joel Harris 00:05:24 That’s Harris vaccines. Yeah. Originally named sera Sera Bio’s CRH, which is Harris backwards.

Matthew Rooda 00:05:32 yeah.

Joel Harris 00:05:33 And then.

Matthew Rooda 00:05:33 We rebranded way better with Harris because there’s still.

Joel Harris 00:05:36 A few vets that call it sera, which is funny, or sera, like the wine, which is. I always thought that was a funny.

Matthew Rooda 00:05:42 Well, I remember too, when you guys ultimately were acquired and I went to the Prometheus Awards and it was like Ed Harris vaccines and Harris vaccines, and it was like the longest train of people walking up on stage like five times. Yeah.

Joel Harris 00:05:57 Well, and we I mean, at that time. So we when I graduated and then joined full time at Harris because I was doing some part time stuff, there was only five of us. And so then we grew that over 7 or 8 years to 55 people and selling and it’s like nine out of the top ten swine producers were in all of North America. I was selling into Southeast Asia.

Matthew Rooda 00:06:22 Can you briefly explain what you did?

Joel Harris 00:06:24 Oh, yeah.

Matthew Rooda 00:06:25 Sorry. So we.

Joel Harris 00:06:28 at the time we called it and the USDA called it an RNA particle. But it really is a mRNA vaccine delivered with a virus like particle or replica particle.

Joel Harris 00:06:41 It’s got a bunch of different names. but these are customized rapid response vaccines. So you can, if you isolate a pathogen in a barn, you can sequence it. And if you know the the right combination of attacks and GS that derive protection or immunity, you can plug that into the system and crank out a vaccine very quickly. so let’s quickly, weeks like at the time we were turning around vaccine in 4 to 8 weeks.

Matthew Rooda 00:07:10 Which historically would have taken years. Years.

Joel Harris 00:07:14 Yeah. I mean, and even the autochthonous players at the time were you had to order large volumes and it would take months. And that process was, you would isolate a pathogen, take it internally, grow it so you grow the live virus and then you inactivate it in some way, make the vaccine. And that would be the product. we did everything, everything synthetically. So there was no live pathogens coming into our facility. We had a high safety profile, and we could be really fast and by really fast.

Joel Harris 00:07:47 The specific example that kind of started the hockey stick moment in terms of growth and revenue was in 2013. As I’m sure a lot of your listeners know, porcine epidemic diarrhea came into the US from China, killed about 8 million pigs. PDV we decided to, make a candidate vaccine for PD, and we got a conditional approval from the USDA about three months before zlotys. So we were about a 20 some person company at the time, and we beat one of the largest animal health players to market with that product and that. And that was really the turning point. I mean, everything after that we.

Matthew Rooda 00:08:33 Just proves how efficiently you could bring something to market and how cost effectively.

Joel Harris 00:08:38 Yeah, yeah. And it was really it was the first time an RNA vaccine had ever been approved. So this is like 2012 when we got the first one in PD was 2013. we helped write a lot of the regulations around how this technology should be governed. flash forward a little bit to Covid.

Matthew Rooda 00:09:02 I was going to say PD was a coronavirus PD.

Joel Harris 00:09:04 It was a coronavirus.

Matthew Rooda 00:09:05 mRNA was what they used, right?

Joel Harris 00:09:07 Yep. And in the same way, that Moderna and BioNTech looked at the SARS outbreak in China and Canada in 2004. That’s what we did because it was a coronavirus. And we knew, that this portion, the spike or S1 protein of the virus, would cause protection. They determined that in the early 2000, and that’s what we did for our early vaccine. yeah. So there’s a lot of corollaries between, proving something and either animal health, veterinary medicine or we were talking earlier, just agriculture and then how it can go into these other industries or be validated in these larger markets later on. but yeah. So then eventually, like you said, we sold to Merck in 2015. I stayed on for, a little over a year doing the business integration and technology transfer in. The last thing I did was help rebrand. well, or the brand transition of the Harris tech to security that it’s known today.

Matthew Rooda 00:10:13 That was approved by Merck.

Joel Harris 00:10:14 American MSD. Yeah. Okay. and then the early and then so I transitioned out and I was approached by three of the initial investors of the ag startup engine, which is a we can talk about that more, but it’s an early seed fund based out of Iowa. And they wanted to create a fund to help early stage ag tech companies get started, because there wasn’t really a robust infrastructure for that that there is today. And we can kind of talk through that transition, because that’s been about ten years. And Michaela came on and we launched just our third fund a couple months ago, which is really exciting.

Matthew Rooda 00:10:53 Congratulations. And we’ll get into the fun of talking about that. Now. We’ll move over to Michaela. Sure. You had a venture that you started in 2014 and you were not just domestic, you were all over the world. So can you tell us a little bit about your story and how you even got into starting a business?

Mikayla Mooney 00:11:12 Yeah, I think somewhat similar to your story, Matt.

Mikayla Mooney 00:11:14 You know, at University College student interested in probably problems across the industry was always interested in agriculture. and while there started a company called Kina Solar where we built Solar Food Dehydrator. So we really built on the model of, you know, we dry commodity crops here in Iowa. It’s very familiar. We got grain bins. You’re using drying technology. Well, what if you apply that to more perishable crops in regions where food security was not as prevalent as it is here in the US.

Matthew Rooda 00:11:43 So mainly Latin America, Africa.

Mikayla Mooney 00:11:45 Yeah, most of our work was over in Eastern Africa, but we had partnerships and distribution in over 50 countries between South America, Africa and Asia. So kind of had product all over. Manufacturing was here in the US, so built a small scale solar powered food dehydrator and then shipped it kind of all over working with smallholder farmers, cooperatives, nonprofits, all on food preservation, value added products, income generation. So did that kind of throughout the years of college. similarly to you, we were pretty fortunate in pitch competitions.

Mikayla Mooney 00:12:17 That’s where we got all of our initial funding was non dilutive capital. I think at the time back in 2014, like I started engine didn’t exist. There was very few venture here in Iowa. So I think we didn’t even think venture was an option. So we bootstrapped that entire company. we’re pretty fortunate with pitch competitions raised about a quarter of a million. That got us kind of initial funding to get up and going and then. Yeah, just bootstrapped through sales and partnerships and eventually, Covid hit in 2020 and with travel restrictions and lockdowns, we wound down the US operations, handed everything off to local partners. And then I transitioned from founder operator into investor. So spent a couple of years at Ice Ventures here in Cedar Rapids, working with Eric and his team, generalist fund investing kind of all across sectors stages here in Iowa. Realized I loved being on the investor side, but really wanted to get back to food and agriculture. So a couple years ago jumped in with egg startup engine to help raise the third fund.

Mikayla Mooney 00:13:16 So that’s my story in a nutshell.

Matthew Rooda 00:13:20 So I’ll dive into your story a little bit too. And maybe at the end we’ll do some free publicity for Clayton for running across the state of Iowa.

Multiple Speakers 00:13:29 We can do that.

Matthew Rooda 00:13:31 when we started our businesses, it was kind of in a weird time. Yes. Where most coastal investment groups were sick of the next app. Yeah, right. Because at that time it was just apps. And I remember hearing constantly. Oh, I’m glad I’m not just seeing another app. there was this desire for practical problem or problems or practical solutions to solving real world problems. And both of us were in environments most people didn’t know very well. And how how important do you think the timing was, even though we didn’t have that venture support in Iowa? How did you feel like the world was responding to food dehydration in foreign countries and and feeding the world in a time where technology was maybe plateauing a bit?

Mikayla Mooney 00:14:21 I think you’re spot on. The fact that, like we had simple hardware, it was a simple solution.

Mikayla Mooney 00:14:26 People understand the concept of drying products like we dry food today. Like, why not take that technology and apply it in an area where food security is incredibly difficult? You have an over surplus of crops coming into the harvest all at once. And what do you do? It sits in the field. It goes to waste. And so I think while we weren’t necessarily pitching investors like the reception we got from conferences, public speaking events, pitch competitions was just like, okay, this is so simple. Like, this is great. Like, how can we help you kind of move it forward? And so I think that allowed us to be so successful in the non dilutive capital we were able to get because we weren’t another app. We didn’t have any software, we didn’t require technology like it was the simplest piece of technology. It didn’t even have a solar panel like it used a natural convection system. So you literally just sat it in the sun and it did its magic. And at the end of the day, you had dried bananas, mangoes, tomatoes, those types of things.

Mikayla Mooney 00:15:22 So I think sometimes, like the simple solutions are what customers really want. and those can be so successful. And sometimes investors miss the point because they’re not in those niche markets or those specialty, I mean, like food security and hog barns are not niche markets by any means, but they’re just not aware of them.

Matthew Rooda 00:15:43 They’re not the main the main thing.

Mikayla Mooney 00:15:44 It’s not the next Facebook. Yeah.

Matthew Rooda 00:15:46 So yeah. And sometimes I feel like startups are and maybe I’m getting ahead of myself but are pushed to over build. Yeah. Or bring in more technology than it’s absolutely necessary to attract the investment. When in reality, the super practical simple solution was the gateway into the industry and kind of can get them into an area where then they could apply more tech and become a little bit more sophisticated.

Mikayla Mooney 00:16:12 I think so, like and I think back to the early days when we started, we, we kind of went back and forth between, do we want to be a nonprofit or do we want to be a benefit corporation? ultimately, we decided to be a for profit benefit corporation because we wanted to own the destiny of where the company was going.

Mikayla Mooney 00:16:28 We didn’t want to be beholden to shareholders. And to your point, sometimes when you bring investors in, you’re beholden to kind of their timelines, their expectations, and you have to be able to manage that in the direction that you want to go. Building the company.

Matthew Rooda 00:16:41 A good, profitable business with a social good tie can quickly be turned into how do we either scale this or kill it? Yeah.

Joel Harris 00:16:49 And yeah. Also aren’t you. You were coming up in the time of all these accelerators though too, right? Like Techstars.

Matthew Rooda 00:16:56 Plug and play was helpful. It was, but it wasn’t, though, because.

Joel Harris 00:17:00 I mean, I think the.

Matthew Rooda 00:17:01 Other thing you get shoot, well, you can.

Joel Harris 00:17:03 Get shoehorned into.

Matthew Rooda 00:17:04 Is that if you were in the egg startup engine was helpful. We’re not an accelerator.

Joel Harris 00:17:08 And that is designed by choice and by, what I was seeing at the time, which is really aggressive terms for taking a lot of your money for being in a program and also having either corporate LPs or sponsors that are, again, are shoehorning shoehorning startups or founders to solve their problems.

Joel Harris 00:17:30 Yeah. And there’s not a if you’re building a software application for Cargill’s supply chain issue. Like it only fits Cargill’s. It’s not going to fit the ATM’s or or anybody else. And so it really limits your market. And if Cargill doesn’t like it, then what did you just build? You know, where can you shop that around. So good point by design.

Matthew Rooda 00:17:49 Kind of manipulative the structure.

Joel Harris 00:17:50 Yeah I mean obviously they have their place and there’s been some some successes that come out of those. But AG started from the start. We were not going to deliver a playbook. We were not going to hold anyone’s hand. It was like if you had the grit and the onus to ask for help from our investors and our network, we will help you. But like, I, we I didn’t have any of this support.

Matthew Rooda 00:18:15 Yeah.

Joel Harris 00:18:15 Well, so like, does everybody need it? Like, I don’t know.

Multiple Speakers 00:18:18 I don’t know, but I think back, like, I feel like.

Mikayla Mooney 00:18:20 We were right on the cusp of like all the universities pushing entrepreneurship.

Mikayla Mooney 00:18:24 And so like pitch competitions were popping up left and right. And to your point, Joel, they were very great early on. But it was it’s so easy to get stuck in that cycle because universities are like, we want our shiny star to be able to put on the front page of the website. It was fun.

Multiple Speakers 00:18:38 It was so fun.

Matthew Rooda 00:18:39 Hey, go to Miami and pitch.

Multiple Speakers 00:18:41 Exactly.

Matthew Rooda 00:18:41 Walk home with 40 grand.

Multiple Speakers 00:18:42 Yeah, it was like.

Mikayla Mooney 00:18:44 It was so exciting. You got the big checks and you’re like, this is awesome. But I think sometimes it’s a distraction because the judges are not your customers. You’re not spending time with the people who are ultimately going to buy the product. But to get started. Like when you just have an idea, like it’s one of the best places to refine your narrative, it’s like get some traction, get some feedback. and so I do think we were incredibly fortunate, like in that 2014 to 2016 window of like universities were popping up pitch competitions left and right.

Mikayla Mooney 00:19:12 They were pushing entrepreneurship in a way that I don’t think they were beforehand.

Matthew Rooda 00:19:18 Yeah, we laughed because when we look back, if what truly ended up being successful for us as a business is an app.

Multiple Speakers 00:19:25 Yeah.

Matthew Rooda 00:19:26 Well, yeah, if we would have been I mean, it’s bigger than that, but, if we would have been joining those pitch competitions with what ultimately made the bigger impact, we.

Multiple Speakers 00:19:38 Think.

Matthew Rooda 00:19:38 You know.

Multiple Speakers 00:19:39 We wouldn’t have won.

Matthew Rooda 00:19:41 We wouldn’t have happened. So. Like everything has to happen at the right timing.

Multiple Speakers 00:19:44 And.

Matthew Rooda 00:19:44 Timing. Timing is so everything. Did you struggle coming out of all of those pitch competitions and all of this stuff with, gearing your message appropriately for your customer audience when your customer was really chasing capital? Because I know I did.

Mikayla Mooney 00:20:01 Yeah. I mean, it was you go from pitching and selling a story and a beautiful narrative of like, this is so great, we’re doing awesome to then, like, you’re actually in the field and like, what you’re telling a judge is not what you’re telling a customer.

Mikayla Mooney 00:20:12 Or even like the partners we were working with. There were so many times a lot of what we had to do was education of like, how do you actually use the dehydrator? You can’t just drop it off and like expect someone to be able to use it and then education on what do you do with the dried products? And so there was so much more to it that like you don’t cover in a pitch competition because it’s just not sexy or cool or like, great, but like the boots on the ground work is so different than pitching.

Matthew Rooda 00:20:36 How much different do you think your experience as a startup would have been if you did have access to $250,000, fair terms from your true, customer segment, as opposed to needing to run around and do all the like because.

Multiple Speakers 00:20:54 It served.

Matthew Rooda 00:20:54 Its purpose. But how much time did it did you waste? Because that’s the only path you felt like you had?

Mikayla Mooney 00:21:01 So it’s a that’s an interesting question because we started my sophomore year in college, and I don’t think I like at that time, I never would have dropped out of college.

Mikayla Mooney 00:21:09 So like if someone had handed me a $250,000 check and be like, here, go run this full time, I would have been like, I think I’m gonna get my degree and finish college. Yeah, and I’m glad I did. But also, looking back now, it’s like the network I built at college is what was valuable, not the piece of paper. I do think it would have forced us to be much more business oriented, like we did get kind of caught in that cycle of pitch competitions because it was fun, it was exciting, it was thrilling. And so I think we would have moved so much faster if we had not spent kind of three years doing pitch competitions, and we had just spent three years focused on sales.

Matthew Rooda 00:21:47 I think it drove a lot of meaningless meetings too.

Mikayla Mooney 00:21:51 Yes, it does, because people are like, I saw you, this sounds great. How can I help? And then you just wasted an hour and it’s like you were a cool person, but you can’t really help me.

Mikayla Mooney 00:21:59 Yeah, yeah.

Matthew Rooda 00:22:00 So to kind of now bounce over to agile startup engine and the work that you guys are doing. Can you talk a little bit about the founding of the startup engine? Because that all started right where Michaela and I were in these business plan competitions. There’s all this hey, go go go talk go talk, go present, go present. We’re winning. We’re bringing in capital. It is serving a purpose, but it’s inefficient time.

Joel Harris 00:22:22 Yeah, yeah I, I so I mentioned it a little bit, so, the genesis around egg startup engine is more, at that time, especially at Iowa State University, you had this other, initiative, the Startup Factory, which was kind of a, I don’t know, university accelerator.

Multiple Speakers 00:22:42 But.

Mikayla Mooney 00:22:42 More like an incubator.

Joel Harris 00:22:43 More like an incubator.

Multiple Speakers 00:22:44 Yeah.

Joel Harris 00:22:45 And they were seeing so and so the like institutional traditional investors around at the time were seeing really cool things come out of there. But it was always super, super early. It was either like an idea or a student thesis or, you know, maybe an MVP.

Joel Harris 00:23:02 If we were lucky and there was no vehicle to like funnel cash into these just to give it a little bit of gas to see if the idea would work or not. And so that was really the ag startup, and it was like, okay, let’s go pull a little bit of money and we’ll write. at the time it was 25 K into an idea or a or a founder. So I came on. So there were three investors. I came on and I found the other seven. So we had ten investors originally. a lot of this was because, an Iowa State student, Colin Herd, had started this company, Smart AG, which was to bring autonomous driving to tractors. And he was our first investment. and then from there, we invested in, 15 companies in total over about three years.

Matthew Rooda 00:23:53 and kind of soul. Was that one of them?

Mikayla Mooney 00:23:55 No, no, we didn’t go through.

Multiple Speakers 00:23:57 Yeah, I was.

Matthew Rooda 00:23:58 I wasn’t one either.

Multiple Speakers 00:23:59 So we’re not. No, no no.

Multiple Speakers 00:24:00 Yeah.

Mikayla Mooney 00:24:00 But Kevin.

Multiple Speakers 00:24:01 So Kevin we got no’s. Well we didn’t even pitch a startup engine.

Mikayla Mooney 00:24:04 But thankfully Kevin Kinley, one of the other co-directors and also running the entrepreneurship programs in the College of Iowa State, he was our first board member at Kennesaw. So super helpful. I think we got a lot of the benefits from start up engine without maybe being an egg startup engine portfolio company.

Matthew Rooda 00:24:21 Kevin’s pretty wise.

Mikayla Mooney 00:24:22 Yeah, Kevin is very wise. But I think Joel, the the other really important thing about ag startup engine is all the capital came from the industry.

Multiple Speakers 00:24:30 Yeah.

Joel Harris 00:24:31 Yeah. So it was all either, large. Well, not large. Well, like family.

Multiple Speakers 00:24:38 Family owned.

Joel Harris 00:24:39 Family owned businesses, large land management companies. some of the institutions around the state.

Multiple Speakers 00:24:48 Farm.

Joel Harris 00:24:48 Are farmers. Yeah.

Matthew Rooda 00:24:51 So can you speak to how you pulled all that together? Because I know the industry people are trying to figure out how do you do that? And you did it. If that’s a secret sauce.

Matthew Rooda 00:24:58 You know, I just.

Joel Harris 00:25:00 I don’t know how I’d do it. Actually, no.

Multiple Speakers 00:25:02 Yeah. How do we do it?

Joel Harris 00:25:04 So what’s interesting is that up until that point at Harris vaccines, we’d raised up through a series B of funding, so different levels. And so I had a lot of experience raising money for like, my own projects or things I wanted to do. And so this was, going out and getting investor dollars to then then go out and deploy. So there’s kind of they call it like being on the other side of the table, you know, from being an operator founder to being an investor. and that first million that we raised was really, it was like philanthropy with upside.

Matthew Rooda 00:25:43 Okay. Yeah. It’s like.

Multiple Speakers 00:25:44 It.

Matthew Rooda 00:25:44 Might lose all of it, but there you go.

Multiple Speakers 00:25:46 Yeah. It was an experiment.

Joel Harris 00:25:48 It was an experiment. And it’s like, here are some case studies of things we think are interesting and would want to put 25 to 50 K in and see where it goes.

Joel Harris 00:25:57 And we didn’t ask for a lot upfront.

Matthew Rooda 00:26:01 How much of that philanthropy was said. You know what I really like Iowa. Iowa State. This is somewhat conjoined to Iowa State. I feel like I’m giving to the university the community through this program.

Joel Harris 00:26:14 Yeah. So there was a big, there was a commitment to a donation to Iowa State. There was a commitment to, at least initially, Iowa based or Iowa founded companies. And that and I kind of pushed that over time. And that evolved because.

Matthew Rooda 00:26:31 yeah, this the same people wouldn’t have put money in if this was maybe a University of Iowa project or.

Joel Harris 00:26:37 I mean, this.

Matthew Rooda 00:26:38 Was all or.

Joel Harris 00:26:38 It was. I mean, we had people from Ames through Des Moines to hear, yeah, that’s cool. So it’s it was from all the borders of Iowa. but, very quickly, though, like, you raise a fund, you got to deploy it. And if there’s not enough ideas happening in the geographic area that you.

Matthew Rooda 00:26:58 Your deal flow.

Joel Harris 00:26:58 Your deal flow, then you got to start looking outside of that geographic area. So I think maybe the eighth or by the eighth or ninth deal, I’d really pushed the group because it is a member managed fund, so that each investor had a say in whether we did a deal or not, a vote. over time, I had to push them and say like, hey, there are really cool things happening outside of Iowa, and we could bring them to the state or connect them to stakeholders in the state, or even convince them to move locations. But we need to start looking outside of the state of Iowa for some of this innovation. And and that’s continued on through now, you know, through our second fund and now through the third fund and, the next member managed fund we’re raising.

Matthew Rooda 00:27:44 So is it fair to say that in your experience now we’re going to do a look back on ten years because you kind of talked about we talked about the, the what it looked like as a founder ten years ago, at least, coming out of college.

Matthew Rooda 00:27:55 what it looked like in the accelerator realm, for you guys to put together a fund. is it fair to say that in ag tech, from a number of deals standpoint, your group has been as successful as anyone on the company going from founding to exit? Maybe not in the multiples as much, but just in helping companies progress to an exit because it seems like you’ve had some really good wins.

Mikayla Mooney 00:28:24 Yeah, I was just doing the math. I think we’re.

Multiple Speakers 00:28:27 At.

Joel Harris 00:28:27 Michaela’s got the numbers.

Multiple Speakers 00:28:29 I don’t.

Joel Harris 00:28:29 I have the feels.

Multiple Speakers 00:28:30 So I think we’re.

Mikayla Mooney 00:28:32 At, out of one one. We’ve had three exits out of fun. Two, we’ve had three exits. so out of, you know, like the last ten year history, we’ve had about six exits. so I think I would say we’re doing really well. We returned money back to investors.

Multiple Speakers 00:28:50 So that’s something most.

Matthew Rooda 00:28:51 Ag tech funds can say.

Multiple Speakers 00:28:53 That. Yeah.

Joel Harris 00:28:54 No, I don’t think so.

Matthew Rooda 00:28:56 What is it that you guys feel like you did differently than everybody else in ag tech that allowed you? Is it.

Matthew Rooda 00:29:07 Yeah. What was different?

Joel Harris 00:29:09 Well, I think I mean there’s the not there’s the return on cash numbers, and those are really important. But I think early on we focused on the founder and the founding team. and you got to remember like it was basically being run by founders or operators. So it’s not finance people or, you know, investment bankers that transition into venture capital. And I’m not digging any of that. I’m just saying it’s a different strategy.

Matthew Rooda 00:29:40 It’s a.

Joel Harris 00:29:40 Different mindset. And you can kind of call, BS on things. Now, we didn’t get everything right. We’ve had a couple shutdowns too, you know, which the whole point of this is that you, you know, it’s a multi shot on goal. Right? So you invest in 15 maybe one of those is a home run and you get a few singles and doubles out of that. And that makes up all the returns, which is really good. So we’ve been a little bit better than that. Like the batting average has been a little better, which is great.

Joel Harris 00:30:09 And that I think the other thing we looked at was Trying to, as much as possible, avoid the trends that were happening in other industries and focus on what the problems actually are in agriculture, which sometimes is labor and sometimes is energy. Or, you know, for a time, climate issues and stuff. So I think we tried to be counterintuitive to what was hot and sexy at the time.

Multiple Speakers 00:30:40 Yeah.

Mikayla Mooney 00:30:41 And I think it’s also just different when, like most fun structures, you’re going to have the management team that’s making the decisions. You might have an investment committee, but the fact that all of the capital is engaged in the industry and they’re all listening to the pitches, helping us, questions, they’ll have calls with founders like that gives you a level of diligence that you don’t always get when you’re pitching to a potential room that has customers. And the customers are like, yeah, this is going to solve my problem. It’s far easier to make an investment. And I think you’ve got this engaged investor group, not just on the evaluation side, but then people that are willing to roll up their sleeves and be partners first customers pilot like advisors to help these founders scale.

Mikayla Mooney 00:31:20 I think that’s part of why it’s been so successful, of if you can invest in founder, and I think a lot of funds try to be value add investors. And I think we view it as like we should write you the check and open doors for you. It just so happens that the doors we’re opening are the checks that like, we’re writing for you. So we’ve got this network of people who can be a customer or help you think about manufacturing or different things like that. And I think that’s been part of the reason the founders have maybe been slightly more successful, and maybe not quite as many shutdowns as others.

Matthew Rooda 00:31:52 You seem to collaborate with each other well too. So learning from each other.

Mikayla Mooney 00:31:55 Yeah, we do a lot with like dinners, round tables, try to build out the community. I mean, it’s hard being in the trenches. We’ve all been there.

Joel Harris 00:32:03 So like, you know, Kyle at Tractor Zoom, right. So if you ask Kyle, he we didn’t I mean we’ve written him a couple checks.

Mikayla Mooney 00:32:11 Two.

Multiple Speakers 00:32:12 Now.

Joel Harris 00:32:12 But not huge checks. And he will tell you that. and I think a lot of our other founders will say this too, that the value we bring is not the dollars. You know, it’s the network and it’s these other kind of intangible things that we can help solve. So I think we want to keep that as part of the ethos as much as possible.

Matthew Rooda 00:33:35 So when I’m working with the industry, a lot of times they’re either optimistic or pessimistic, pessimistic about technologies and ideas coming down the path. And so I might talk to them a little about, you know, here’s here’s the funds that are active. But when you do raise a fund, you get about, what, 3 to 5 years to deploy it and then about five years to, to let that let that grow and then reap the benefits. And then you might start a new fund. But a lot of funds started in that 14, 15, 1617 range in ag tech. So a lot of funds are coming due and because a lot of funds didn’t fare as well as you guys, I don’t think a lot of ag tech funds are getting renewed or there’s new.

Joel Harris 00:34:16 It’s harder.

Matthew Rooda 00:34:17 It’s harder.

Multiple Speakers 00:34:17 It’s harder.

Matthew Rooda 00:34:18 Yeah. Which means there’s less capital today available potentially for AG than there was over the past 5 to 10 years.

Joel Harris 00:34:27 And it’s not an AG specific. That’s in general. I mean I mean that’s why I think you get a lot of excitement around the, the space and anthropic and open AI IPO announcements because there’s a lot of, investor dollars that have been tied up for a long time. I mean, space is super old. Right. Yeah. So I think that’ll also open up some cash down, you know, downstream and, free some things up in AG. But, yeah, I mean, to your point, I mean, we just have some investors, either individuals or family offices or even you see it in the corporate VC side that’s pulling back because they’re. They’re like, we’re in 30 deals and we haven’t seen a dollar yet. So like, what we can’t do anymore.

Multiple Speakers 00:35:12 Well, I.

Mikayla Mooney 00:35:13 Oh, sorry.

Multiple Speakers 00:35:13 Go for it.

Mikayla Mooney 00:35:14 I was just going to say I think it’s really hard to I mean, think back to your own journey. You’re, what, 11 years in?

Multiple Speakers 00:35:20 Yeah.

Mikayla Mooney 00:35:20 Now, like, early stage investing is really hard, especially in agriculture, when things are cyclical in nature.

Mikayla Mooney 00:35:28 Like, you have to build the trust in order to adopt. Like adoption is going to be small subset scale. Maybe then a whole barn or a whole herd or across the entire operation. Like it just takes time. That AG doesn’t always fit this kind of ten year time horizon. You’ve got to have patient capital. because it is going to take time. But that doesn’t mean the exit is not going to be lucrative. It’s just not going to be, you know, 7 to 10 years maybe from the day you start.

Matthew Rooda 00:35:55 So you’ve sitting in a lot of different roles, right? The founder, you went over to Iowa Startup Accelerator or Iowa, Iowa Start Ventures.

Multiple Speakers 00:36:03 Yeah. Ventures.

Matthew Rooda 00:36:04 And then, now our I start up engine when I am talking with many of when we were trying to raise capital over the past five years, there’s a lot of funds that are saying, I’m not touching animal AG unless it’s a biologic or a vaccine.

Joel Harris 00:36:23 Yeah. Even then there’s only like ten. So it’s.

Joel Harris 00:36:25 Yeah.

Multiple Speakers 00:36:25 Like.

Matthew Rooda 00:36:26 Yeah.

Joel Harris 00:36:27 So it’s a small subset.

Matthew Rooda 00:36:28 I tell the industry and I asked their reasoning and they said good ideas in animal AG don’t succeed fast enough. And bad ideas do not fail fast enough. And so it creates creates all of these issues. And I tell producers that outside capital view the industry as unenforceable. I’m asking both of you who have lived in this. When you look at animal ag versus row, crop energy, climate, all the other things that are made up in AG. Where does animal AG rank in your mind. Is at the bottom of what’s investable. It’s the most. Is it the most dangerous area to throw your money?

Mikayla Mooney 00:37:10 I don’t think so.

Multiple Speakers 00:37:11 Okay.

Mikayla Mooney 00:37:12 What? 45% of our portfolios, livestock, animal health.

Multiple Speakers 00:37:15 Like.

Mikayla Mooney 00:37:15 We kind of view.

Multiple Speakers 00:37:16 Livestock.

Joel Harris 00:37:16 Is unique.

Mikayla Mooney 00:37:17 Yeah, it’s very unique. We view it as like, an underserved industry. Like, I think you kind of see this, like, row crop got it’s like dollars and prime time.

Mikayla Mooney 00:37:27 Then specialty crop and like animal AG is finally coming to the forefront. Okay. So like it does just feel like maybe it’s been behind or overlooked. And part of that is because I think if you don’t understand animal ag tech, it’s very hard to invest in it.

Multiple Speakers 00:37:41 because.

Matthew Rooda 00:37:41 Flashy things that should make sense don’t can be way ahead of their time.

Joel Harris 00:37:46 Yes, yes.

Matthew Rooda 00:37:47 Wearables, computer vision, all that stuff existed eight, nine years ago.

Multiple Speakers 00:37:51 Yes.

Mikayla Mooney 00:37:52 And we saw a lot of those deals. And those deals are not going on.

Matthew Rooda 00:37:56 Yes, a couple survived like vents. And what’s the one that just had the $1.5 billion valuation?

Joel Harris 00:38:02 Halter.

Matthew Rooda 00:38:02 Halter. I remember being at Iowa and Josey Jewell played football at Iowa, was in the entrepreneurship side. He was actually building a, a startup, with a mentor of ours that was virtual fencing. And they were going back and forth with halter on IP conversation. So even halter.

Joel Harris 00:38:20 Yeah.

Matthew Rooda 00:38:20 Who I think’s in the 20 millions on revenue, which isn’t, isn’t crazy.

Matthew Rooda 00:38:24 It’s good in ag tech but not crazy. It took them maybe ten, ten, 11 years.

Joel Harris 00:38:29 I think it’s important to think about the signals that again, what I really think we try to do well at AG Startup Engine is look at the things that maybe aren’t obviously correlated to what a traditional animal ag tech investment would be. I mean, I would say like, again, like labor solutions or automation, like the problems are we can’t get enough people to work in the barns. Yep. on the other side of this, you know, what’s become really prevalent in the zeitgeist is protein consumption. So where’s all this protein going to come for come from? If we can’t continue to produce it more efficiently and drive costs down? Right. So I think there’s these trends that on the face don’t look like they have an agriculture or even animal ag tech correlation. But if you dig into it, there’s probably something there.

Matthew Rooda 00:39:22 Well, a couple more interest rates are high. Yeah. Barn costs are high.

Multiple Speakers 00:39:26 Yep.

Matthew Rooda 00:39:27 We’re energy. We are. We can’t expand the way we have for 30 years. And so to find growth, people have to start looking internal at efficiency. When we were driving stuff ten years ago, you could still build to grow. So why am I going to focus on doing it the hard way, when I can just go get the capital and build another barn and solve my problem the easier way? Yeah, sure. Can’t do that anymore.

Joel Harris 00:39:53 And there’s a million pigs on the road at any given moment. Right. And so the cost of that has just gone up with diesel. It’s like, so there’s all these things. So I don’t know. I don’t think it is. We don’t look at it as a riskier. No, I mean I’m biased because I live it. I mean but you’re right. It’s very undercapitalized.

Matthew Rooda 00:40:12 is it the is it one of the more dangerous areas of AG if you have no background in the animal ag side of things?

Joel Harris 00:40:20 Yeah, I probably if you talk to me.

Matthew Rooda 00:40:23 It’s.

Joel Harris 00:40:23 Like because I, there’s some people I’ll talk to and it’s like, oh, you just have no idea what you’re getting into.

Multiple Speakers 00:40:29 At all. Well, and I.

Mikayla Mooney 00:40:30 Think it’s easy to fall into the trap if you’ve never invested in like animal or ag tech and you’re coming from kind of a traditional venture VC mindset like that growth playbook doesn’t work. It is not grow at all cost and act like you can’t pump more money in and expect to get more out. So it’s a little bit more of a steady growth progression. And so sometimes like we see founders over capitalizing. And I think that’s one of the biggest risks of you raise too much from people who don’t understand it, and then they want you to grow super fast, spend all this money and, you.

Multiple Speakers 00:41:06 Know, two years that your debt.

Mikayla Mooney 00:41:07 Yeah. And two years later, you’re not really any further than you were two years ago.

Matthew Rooda 00:41:11 Yeah. I mean, on our side, I mean, we’re nearing a million sales.

Matthew Rooda 00:41:14 And the question from investors or from partners is, you know, like, what are you doing? Marketing. It’s like in any other space, marketing might be the category you throw the most resources at to drive growth. It’s relationship driven. It’s you need to prove it. You need to be involved. You need to.

Multiple Speakers 00:41:35 Yeah.

Matthew Rooda 00:41:35 Be committed to the industry to find growth and just throwing dollars at marketing and AG, depending on the category, just doesn’t always work.

Mikayla Mooney 00:41:46 No, it’s it’s far more word of mouth, like you’re going to get your best customers from a customer referral that talks to this hog farmer down the road, that they know each other. And like they all talk. And it’s a very small industry, you know.

Matthew Rooda 00:41:58 And the scaling is more people talking. Yeah. Not necessarily. You can’t just throw them in a room more often.

Multiple Speakers 00:42:03 Right. Right.

Mikayla Mooney 00:42:06 Yeah.

Matthew Rooda 00:42:07 So when you, when you look at I mean, even if you look at performance livestock analytics. Right. Records with some some unique approaches.

Matthew Rooda 00:42:16 Records for the beef industry. I mean, Tom Stein had built records for swine in the 80s. Yeah. Like most investors, if they’re looking at that space and that’s coming across their their table, if they are traditional VC, they’re probably saying this is too, too simple for me. But it was genius because they figured out a way to do it well. And they had a multiple of multiples.

Multiple Speakers 00:42:39 And that’s what their customers.

Matthew Rooda 00:42:40 Because that’s what the customers wanted.

Multiple Speakers 00:42:42 Yeah, yeah.

Matthew Rooda 00:42:42 It was practical.

Multiple Speakers 00:42:43 Yeah. Yes.

Matthew Rooda 00:42:44 It didn’t happen because at that time, machine learning was the buzzword.

Joel Harris 00:42:47 And it was an app.

Matthew Rooda 00:42:47 It was an app. Machine learning. It’s an app. They didn’t do machine learning.

Multiple Speakers 00:42:53 But it.

Matthew Rooda 00:42:53 Was.

Multiple Speakers 00:42:53 An app.

Mikayla Mooney 00:42:54 Easy to use app.

Multiple Speakers 00:42:55 That farmers can.

Joel Harris 00:42:56 Big red and green buttons.

Multiple Speakers 00:42:57 Yeah, because.

Joel Harris 00:42:58 They’re for, you know, Dane and Dustin’s like parents. There. Like, if my parents can use it, then it’s going to be successful.

Multiple Speakers 00:43:04 Yeah.

Matthew Rooda 00:43:04 I keep feeling as though finding that practical end isn’t what sexy for VC.

Multiple Speakers 00:43:10 It’s not.

Matthew Rooda 00:43:11 But it is what consistently seems to work. It’s like, is there a missed connection there between what VC expects in ag tech hitting all the buzzwords being to date with where tech is in other sectors, to feel like there’s that upside, when in reality you almost need to go back to the basics of just what solves the problem.

Joel Harris 00:43:32 I think it’s hard. I mean, to play like devil’s advocate for the funds a little bit. It’s, you know, they have a thesis that they go out and raise dollars from investors, which then are called these like LPs limited partners. And they’re saying, we’re gonna do a 7 to 10 x return on your money or whatever, whatever it is, I don’t know. Right.

Multiple Speakers 00:43:55 3.

Mikayla Mooney 00:43:55 To 4 is probably more.

Multiple Speakers 00:43:56 Realistic.

Joel Harris 00:43:57 But, you know, maybe. Maybe like though seven years ago, though, they were probably 7010. Right. So so then, they start looking at earlier in earlier deals because that’s how you get that whatever three, 7 or 10 x multiple is, sometimes you have to be in so early because you’re not going to get the billion dollar exit.

Joel Harris 00:44:17 You’re going to get the I think if you look up like the, the average like the angel investor network, they have stats on this, like most startups get bought between 40 and 120 million, you know, so it’s like, but that’s not what makes the headlines and that’s not how you raise your funds. Right. So I think especially in the Midwest, we need to have a, a better, mindset around creating exits at this, like 80 to 100 million then, like multiples of that versus $1 billion exit, like having $1,000 million exits would be way more valuable for the ecosystem. And reinvestment into these into these areas, whether it’s animal, egg or crops or whatever.

Matthew Rooda 00:45:03 That it’s not an outlier.

Multiple Speakers 00:45:03 Anymore. Yeah, yeah, yeah.

Mikayla Mooney 00:45:05 I also think like we’ve talked about this before. I think some of the most successful founders are really bad at fundraising because they’re so like, I don’t mean that in a bad way, but like, they’re so focused on their customers, they can speak to their customers.

Mikayla Mooney 00:45:19 And speaking to your customers like we were talking about earlier is very different than pitching to investors. And those are two very different skill sets. And it’s like, which one would you rather have someone that can tell me, like sell me a shiny story, or someone who can actually go speak to my customer and get them to buy it? So I think sometimes that’s the disconnect that like, you can build a very successful business, but you struggle on the fundraising because it’s not this sexy AI, machine learning or.

Matthew Rooda 00:45:45 The two audiences, and you need to know who you’re talking.

Multiple Speakers 00:45:47 To.

Matthew Rooda 00:45:47 Exactly, because you can pitch completely different stories and it be honest.

Multiple Speakers 00:45:53 Yeah, yeah, yeah.

Matthew Rooda 00:45:55 just because one is made more practical than the other. yeah, both can exist. And I guess that’s in a, in a world to kind of move the story forward, hear the conversation forward. in a world of AI, there’s never been a time where it’s easier to maybe mislead or diagnose whether or not the company I’m talking to is legit or not.

Matthew Rooda 00:46:20 because you can make some things look pretty. Pretty capable.

Multiple Speakers 00:46:24 Pretty.

Matthew Rooda 00:46:24 Easy. but the back end of that might be a disaster. So if I’m a producer, having you’ve been at all the stages, same with you. And and you’re kind of seeing it today and what you’ve seen over the past ten years. if I’m a producer and I’m looking at a startup and I’m considering, should I work with them, should I give them a shot? What are some things that I can look out for. What are the positives and what are some negatives? Like you said, you guys knew how to call the bullshit. How can people do that? Well? And do they? Do they need to align with a group such as yours or somebody say, hey, can you can you help me here? Or is this something that they should? They can learn on their own.

Joel Harris 00:47:11 Well, they definitely should come to us.

Multiple Speakers 00:47:13 Yeah.

Joel Harris 00:47:14 I mean, there are other funds out there that have producer groups, you know.

Joel Harris 00:47:18 Yeah. and I think and, and then there’s other angel networks that are just straight up producers that are directly investing into these things. So, I mean, I do think there’s kind of like, if you’re buying a product, to put on your farm or some piece of equipment, like you should always have that, sanity check with, you know, your neighbor or like, the community that you’re in, right? Yeah.

Matthew Rooda 00:47:45 Do producers need to find a community to better evaluate ag tech other than each other.

Multiple Speakers 00:47:56 I mean.

Joel Harris 00:47:57 Yeah.

Mikayla Mooney 00:47:57 Maybe. I mean, I think for like a lot of the producers we talked to and this is maybe a slightly different angle to answering your question. Yeah, but a lot of founders will pitch producers and it may be this really great solution. But maybe back to some of the like simple, practical. A producer is looking at a technology and they maybe have to spend 90s per animal on that, like with that technology. So then you take that times a thousand head operation that doesn’t math correct.

Multiple Speakers 00:48:28 Yeah.

Mikayla Mooney 00:48:28 So like I think that’s sometimes the disconnect of like producers will listen to a pitch and they’re like, I can’t implement this. I don’t have time in the day to do this. So like, even if you think you’re saving me something or like if feed efficiency is better or reproductive health is better. Like I can’t justify implementing it. So I think sometimes there’s a disconnect. So I do think it is incredibly valuable. And what producers really should do is give that direct feedback to the founders. And sometimes they’re not always the best at that. Like I think sometimes in the Midwest, we try to be too nice and we don’t want to tell people no. We’re like, maybe give that critical feedback. But I think that’s one of the best things as like an industry we can do is be honest with that founder and say, like, this isn’t going to work. And like, this is what I would need to see in order for it to work.

Joel Harris 00:49:15 Yeah. And I think, there’s a lot of excitement, especially in academia.

Joel Harris 00:49:22 Or like, I’ll just take biologicals as an example. Yeah. You know, there’s a lot of cool stuff that can work in the lab at small scale, or there’s a lot of interesting results you can get by shooting up a mouse with something and seeing what it prevents or what it cures or, but on the, you know, on the one hand, once it meets the field, once it’s on field or in the producers hands, things totally change. And then if you’re looking at who’s going to buy you down the road, you know, all the large animal pharma companies do not care about any data unless it’s target species data. Real.

Matthew Rooda 00:50:00 And then they did it with a mouse. It’s like yeah, cool.

Joel Harris 00:50:03 No one cares.

Matthew Rooda 00:50:03 We don’t we don’t have a mouse.

Joel Harris 00:50:05 Yeah. And then and then the step after that is like, okay, you did this in a research barn. Like, well, it’s going to act differently than in a commercial barn operation. Right. So I think.

Matthew Rooda 00:50:15 Well, then one commercial barn is not enough either. Well, did you go system wide? Well, well.

Joel Harris 00:50:19 I think it just depends like. Yeah, if you’re talking to like, Tyson, like. Yeah. Or Smithfield or whoever, there’s those. But if you’re talking to the smaller, producer or people of the co-op, I mean, those are I think the things that you could ask is like, okay, like, are you trying to sell me this? because you have proven it’ll work in a system like mine? Or are you asking me to partner with you to help you get that data? And if so, what do I, the producer, get out of that? Yeah, and I think that’s a place to start, because.

Multiple Speakers 00:50:52 And we need more and we need more. We need.

Mikayla Mooney 00:50:55 Way more.

Multiple Speakers 00:50:55 Of that.

Joel Harris 00:50:56 And and that’s what’s in our group. Yeah, we have producers that will do that.

Matthew Rooda 00:51:00 And give me an ownership stake. Small. Yeah. But for my efforts in time.

Joel Harris 00:51:04 Not the 7% that the accelerators take, but, you know. Yeah. Something meaningful or or it’s you’re you go back to the software analogies. You could be a beta tester for this, which will give you access to when we fully launch our commercial ready product. I mean, I think those are the so maybe it’s it’s either a community or just educating yourself a little bit on like, you know, as a startup, the risks are you implement something and in three years they run out of money and now you have this piece of either software, which is maybe a little bit easier to deal with. But worst cases, you have some crazy piece of equipment or drone that is unserviceable because the back end isn’t. Yeah, it just stops working and then you gotta, you know, haul it off. Whatever.

Matthew Rooda 00:51:53 Yeah. Equivalent there in the swine industry be electronic cell feeding systems. Put that in. And that’s supposed to last me 20 years in the company leaves after eight.

Multiple Speakers 00:52:01 What do you do.

Joel Harris 00:52:02 Yeah I mean yeah, window dressing isn’t new. You know, AI just makes it look probably harder to discern. Yep. But.

Matthew Rooda 00:52:11 one thing.

Joel Harris 00:52:12 The opportunity though there though too, is like, now, AI can some of the things that was so daunting in terms of managing different data or the data that companies collected over a decade can now be analyzed so much faster. So I think it’s almost like a pendulum swings about to happen where like the guy that had this idea on counting pigs ten years ago, this might actually, like, happen now because the computers, there. So and that’s a timing thing too right. Like yeah.

Matthew Rooda 00:52:43 Yeah. One thing we’ve noticed at least I’ve noticed with some of the companies that have come in, found initial success but died off, is that the producers will say they came in. They were smart, eager to collaborate. And then after three years, it became clear that the only way progress was going to happen was if the producer was the visionary. So I think one of my call outs would be collaborations.

Matthew Rooda 00:53:12 Good. But can they independently. Do they have an independently have a vision or are they going to.

Joel Harris 00:53:19 Producer or the startup.

Matthew Rooda 00:53:20 The.

Multiple Speakers 00:53:20 Startup.

Matthew Rooda 00:53:21 Or are they going to rely on the producer to guide the company down every path? Because at some point the producers get sick of having to drive the vision.

Multiple Speakers 00:53:31 But how much stuff, how much of that.

Mikayla Mooney 00:53:33 Comes from founders who come from the industry versus founders who have an idea that want to enter.

Multiple Speakers 00:53:37 The industry.

Matthew Rooda 00:53:38 It’s the.

Multiple Speakers 00:53:38 Latter. And that’s the.

Matthew Rooda 00:53:40 Out of the industry because they they don’t know. But they have the money. They have the talent. They have the willingness to collaborate. But at some point that doesn’t scale well.

Mikayla Mooney 00:53:49 Well. And if you don’t understand the industry you’re trying to operate in, you can’t be a visionary for that industry. It’s very hard because you don’t want you don’t have the background to know what.

Multiple Speakers 00:53:58 Yeah.

Matthew Rooda 00:53:58 So I don’t think it’s black and white. But how important do you think it is that that person has that industry experience to drive the vision? Like at what point, at what point does that person or maybe it’s all right, two years is acceptable, but after two years, you should be involved enough in this industry to be able to paint your own picture.

Matthew Rooda 00:54:17 Like, what does that need to look like out of a founder or out of a company I’m working with?

Joel Harris 00:54:22 Well, I think it is part of this, persona that we try to identify that they have some sort of deep, either technical knowledge or industry knowledge, and then can find the technical people to succeed. Right. Like, we’ve seen that in a few cases, I feel like.

Multiple Speakers 00:54:39 Yeah.

Mikayla Mooney 00:54:39 I mean, I think, like, ultimately when you’re investing early. Like, it comes down to the founder. If the founder can’t tell you where they’re going. Like, it’s not our job to tell them it’s not their customers job. So like, we if, like, if the founder can’t tell us, we’ll probably pass on the opportunity because like, the founder is the one that has to drive the ship. It’s not us, it’s not the customer. And if they don’t have enough conviction to tell us where they’re going, like the investment is not going to go anywhere.

Multiple Speakers 00:55:07 Sir.

Matthew Rooda 00:55:10 Joe, you look unsure.

Joel Harris 00:55:12 No, I’m just thinking of, like, deals.

Multiple Speakers 00:55:13 That we.

Joel Harris 00:55:14 Were looking at and ones where we’ve been like, you should really do this.

Multiple Speakers 00:55:18 Yeah. It’s like, oh, wait.

Matthew Rooda 00:55:21 So when you look at the next ten years, you guys just close the fund. Congrats. You got five years to deploy. Maybe it’s five. I don’t know what your bylaws are, but.

Multiple Speakers 00:55:31 It’s five ish. Five ish. Yeah.

Matthew Rooda 00:55:33 What Excites you enough to go do another fund? And what do you think is going to define success or failure for people in ag tech running a fund? And what should producers be excited about when when they hear there’s more money coming into the space?

Mikayla Mooney 00:55:56 I mean, I think there’s something infectious about being around founders who have the vision. So like it’s exciting to get up every day. And I think for us, the next fund, well, so the fund we just closed was a follow on fund of like we were writing these small checks and we couldn’t support these companies as they scale.

Mikayla Mooney 00:56:14 So it’s like, okay, let’s fix that problem. we’re going to do another member managed fund here, kind of early stage idea fund. But as we think about kind of the future, you know, having a bigger fund just allows us to write bigger checks and maybe fill some of that gap of there’s not a lot of lead investors in this space.

Multiple Speakers 00:56:33 But.

Matthew Rooda 00:56:33 Series B stage is kind of.

Joel Harris 00:56:34 Dead.

Multiple Speakers 00:56:35 A is a yeah, even.

Mikayla Mooney 00:56:37 Even seed.

Multiple Speakers 00:56:39 Like. Yeah, it’s.

Mikayla Mooney 00:56:40 It’s just a lack of capital. So it’s like a bigger fun would allow us to play a more meaningful role in some of those spaces. Right. Bigger checks, help founders continue to scale and grow. and I think when we so like, that’s where we want to go. I think that’s exciting. And then I think when we look at kind of the industry as a whole, one of the things that I think is so interesting is we’re seeing more and more like vertical integration of like you start in a wedge, you continue to build on top of it.

Mikayla Mooney 00:57:07 And how do you solve more of those problems? By just building on the existing solution. And I think that’s so exciting because you have you’re owning more of that supply chain. You have more upside. The challenge with it is that’s not a five year journey like that is a long time ago.

Matthew Rooda 00:57:23 And Tam is hard to factor on that deal.

Multiple Speakers 00:57:25 Because yeah.

Matthew Rooda 00:57:26 Like your total addressable market continues to grow. But what can you prove now?

Multiple Speakers 00:57:31 Yeah.

Matthew Rooda 00:57:32 Current market size.

Mikayla Mooney 00:57:33 So I think it comes down to like you have to have patient capital. And like, I think as investors, it’s our job to communicate that with all of our investors of here’s the realistic expectations. We’re not trying to sell you on a 20% IRR fund return. Like I think we can hit something in that ballpark. But it’s we have to be patient. We’re in it to help the founders. And like, it’s our job to kind of roll up our sleeves where we can and understand it’s going to be, you know, a long time horizon.

Mikayla Mooney 00:57:59 But the upside is going to be bigger.

Multiple Speakers 00:58:01 Sure.

Joel Harris 00:58:03 Yeah. I mean, I’m excited about this democratizing, democratizing some of the technology that’s kind of been closely held for a long time. And maybe that’s what can get to producers sooner. it’s been a crazy transition, I think, the last ten years, to think about how, especially in swine production, how guarded? well, in all livestock guarded they are about their data, Their premises, like all these things. And now they’re letting ChatGPT or cloud look at all this stuff. so we’re in a really weird, weird thing that’s happening.

Matthew Rooda 00:58:42 I think producers data is far less valuable to other people than what they think it is. Yes. It’s not proprietary to in most scenarios. And I think for a while there and I guess venture capital believed, oh, we’ve got the data, we’ve got the data. We’re going to be able to sell it and make millions. And that has been proven false in so many scenarios that if I’m a producer, like, one thing we’ll compare it to is the industry trying to figure out demand.

Matthew Rooda 00:59:12 And I’ll point out the fact that the industry now knows how to improve demand with customers, to help the customer and help them by paying for data from consumer purchases.

Multiple Speakers 00:59:24 Sure.

Matthew Rooda 00:59:26 If the producers had a little bit more comfort with sharing data in an appropriate way. It’s probably going to empower groups to come back and bring value back to the farm.

Joel Harris 00:59:39 Well, I guess.

Matthew Rooda 00:59:40 We hold it tight to our chest. That’s not going to necessarily go anywhere.

Joel Harris 00:59:43 Yeah. And that’s why I guess what I’m trying to say is that that I think you’re absolutely right. Everything’s been siloed for way too long because they they think there’s this intrinsic value in it and exclusivity and all these things. When you start to break some of that up, either by choice or kind of like what the AI companies did initially, they just took everything. You know, they scraped the internet and, you know, you could go back and forth on the legality or the copyright infringement on that or not. But the fact is, like once those dam walls break, there’s a tremendous amount of things that can come out of that, that I don’t think we even really know what the insights could be.

Multiple Speakers 01:00:22 Yeah.

Matthew Rooda 01:00:23 Which is exciting. Yeah, it’s very exciting.

Joel Harris 01:00:25 And I, and I would argue that it’s really held back efficiencies by everyone being thinking that their, that they have secret sauce when everybody’s sauce tastes the same.

Matthew Rooda 01:00:36 Yeah, it they’re not all. Everybody’s not a snowflake. Yeah. We’re we’re solving the we’re we’re facing the same problems day in and day out. Just they look slightly different. Yeah. So ag startup engine, is that something that, is open to more people in the industry getting involved with it? Like, does it make sense for people to get involved with you guys if they’re interested? Or are you guys kind of set with your with your with your group at the moment?

Joel Harris 01:01:01 No, I mean, I mean the network’s expanding it. And like I would say there’s other ways to be involved. Like, you don’t have to be an investor. You know, we have we have sponsors. We have, you know, vendors that just want to get plugged into the startup ecosystem.

Joel Harris 01:01:16 we have annual events that we put together that are open to the public to, there’s lots of different ways to do it. And you can find us on, you know, the web and these other social media channels. But, yeah, I mean, I think we’re always looking for other groups that want to get involved.

Mikayla Mooney 01:01:35 Yeah, I think if people have an interest in innovation in tech, they should reach out. Happy to chat. Whether it’s connecting you with a startup company that could solve your problem or plugging in and just kind of seeing where what we’re seeing. I’m always happy to chat.

Multiple Speakers 01:01:49 Yeah.

Matthew Rooda 01:01:51 The close things up. I’ll ask you guys each a question and it’s going to be if you could go back in time and have dinner with any historical figure, who would it be? I actually ask you two questions. I’ll be the first one.

Mikayla Mooney 01:02:08 I would probably want to have dinner with Norman Borlaug. I feel like I got to, dig in pretty deep through, like, middle school.

Mikayla Mooney 01:02:16 High school with, like, National History Day, world food prize. Got to meet some of his family.

Multiple Speakers 01:02:22 That that would.

Matthew Rooda 01:02:23 Give us a little.

Multiple Speakers 01:02:23 Bit of a brief.

Matthew Rooda 01:02:24 On who.

Multiple Speakers 01:02:24 That is.

Mikayla Mooney 01:02:24 Yeah. So Norman Borlaug is the father of the Green Revolution. From a tiny small town in Iowa. Cresco area. So that’s where my grandparents are from. but basically developed wheat or rust resistant wheat and revolutionized kind of commodity crops for what they are today. So but like, super humble small town farmer.

Matthew Rooda 01:02:47 Would you go back to his day or come bring him forward?

Mikayla Mooney 01:02:52 I think it’d be interesting to bring him forward and see kind of what he thinks about where, like technology and innovation are today.

Multiple Speakers 01:02:58 Yeah.

Mikayla Mooney 01:02:59 Yeah.

Matthew Rooda 01:03:00 How about you, Joel?

Joel Harris 01:03:03 I don’t know why I went to this just because I, I was thinking of Sir Arthur. Sir Arthur Conan Doyle, the author of the Sherlock Holmes. Yeah. And I don’t know why I. I’ve been thinking a lot about just, the structure of narratives and stories and how we, like, communicate things.

Joel Harris 01:03:21 And I’ve always been a big fan of of that and the humor in that. So I don’t know. I’m very big into, especially non-fiction stuff as well, but like how stories get communicated and how they’re remembered. So I don’t know why. I just kind of went to that for some reason.

Matthew Rooda 01:03:40 So last question’s easy. What’s your favorite cut of pork?

Joel Harris 01:03:45 Well, Michaela just started eating me.

Multiple Speakers 01:03:47 Did actually just start eating meat again.

Mikayla Mooney 01:03:50 it’d probably be ribs.

Multiple Speakers 01:03:51 Yeah, yeah.

Matthew Rooda 01:03:52 Do you like them? Dry rub or sauce sauced?

Multiple Speakers 01:03:54 All right.

Joel Harris 01:03:57 I mean, I I’m a big pulled pork. I have a smoker, all the smoker accessories and different thoughts, and I probably I lean toward, like, the Carolina sauce side. Yeah.

Matthew Rooda 01:04:11 Lately, I think that a good Carolina pulled pork.

Joel Harris 01:04:16 Yeah.

Matthew Rooda 01:04:17 Is untouchable. Yeah, but it is so narrow you can.

Joel Harris 01:04:23 It’s unforgiving.

Matthew Rooda 01:04:24 It’s so unforgiving. Like it can be the nastiest pulled pork or the absolute best. And it heats just as good as insane.

Matthew Rooda 01:04:33 Yeah. It’s insane. So shout out to North Carolina on the pulled pork. It it is better than than Kansas City.